Revision as of 19:40, 21 October 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified and watched fields - updated 'ChEBI_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or bugs)← Previous edit | Revision as of 07:47, 25 November 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs)Next edit → | ||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| Verifiedfields = changed | | Verifiedfields = changed | ||
⚫ | | verifiedrevid = 462262233 | ||
| Watchedfields = changed | |||
⚫ | | verifiedrevid = |
||
| IUPAC_name = 5-nitroquinolin-8-ol | | IUPAC_name = 5-nitroquinolin-8-ol | ||
| image = nitroxoline.png | | image = nitroxoline.png | ||
Line 33: | Line 32: | ||
| ATC_suffix = XX07 | | ATC_suffix = XX07 | ||
| PubChem = 19910 | | PubChem = 19910 | ||
| DrugBank_Ref = {{drugbankcite| |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | ||
| DrugBank = DB01422 | | DrugBank = DB01422 | ||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ||
| ChemSpiderID = 18756 | | ChemSpiderID = 18756 | ||
| UNII_Ref = {{fdacite| |
| UNII_Ref = {{fdacite|correct|FDA}} | ||
| UNII = A8M33244M6 | | UNII = A8M33244M6 | ||
| KEGG_Ref = {{keggcite|correct|kegg}} | | KEGG_Ref = {{keggcite|correct|kegg}} |
Revision as of 07:47, 25 November 2011
Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.021.513 |
Chemical and physical data | |
Formula | C9H6N2O3 |
Molar mass | 190.156 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Nitroxoline is an antibiotic.
It was recently discovered that nitroxoline has antiangiogenic properties, which could make it useful as an anti-cancer drug.
References
- Pelletier C, Prognon P, Bourlioux P (1995). "Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains". Antimicrob. Agents Chemother. 39 (3): 707–13. PMC 162609. PMID 7793877.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - Joong Sup Shim, Yoshiyuki Matsui, Shridhar Bhat, Benjamin A. Nacev, Jing Xu, Hyo-eun C. Bhang, Surajit Dhara, Kee Chung Han, Curtis R. Chong, Martin G. Pomper, Alan So Jun O. Liu (2010). "Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer". J Natl Cancer Inst. 102 (24): 1855–1873. doi:10.1093/jnci/djq457. PMC 3001967. PMID 21088277.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)
Antibacterials: others (J01X, D06AX) | |
---|---|
Glycopeptides Lipoglycopeptides | |
Polymyxins | |
Steroid antibacterials | |
Imidazole derivatives | |
Pleuromutilins | |
Nitrofuran derivatives | |
Other antibacterials |
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |